4.7 USD
+0.24 (+5.38%)
4.7 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to SLDB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.47. This target is 229.15% above the current price.
SLDB was analyzed by 19 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SLDB.
In the previous month the buy percentage consensus was at a similar level.
SLDB was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-05 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-04 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-04 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-13 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-06-26 | Citigroup | Initiate | Buy |
| 2025-06-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-06 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-16 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-16 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-05-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-07 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | Truist Securities | Initiate | Buy |
| 2024-12-13 | Wedbush | Initiate | Outperform |
| 2024-12-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-10 | JMP Securities | Initiate | Market Outperform |
| 2024-11-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
SOLID BIOSCIENCES INC / SLDB FAQ
Can you provide the average price target for SOLID BIOSCIENCES INC stock?
19 analysts have analysed SLDB and the average price target is 15.47 USD. This implies a price increase of 229.15% is expected in the next year compared to the current price of 4.7.
Can you provide the consensus rating for SOLID BIOSCIENCES INC stock?
The consensus rating for SOLID BIOSCIENCES INC (SLDB) is 86.3158 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover SOLID BIOSCIENCES INC (SLDB) stock?
The number of analysts covering SOLID BIOSCIENCES INC (SLDB) is 19.